Eighty Percent of New Wegovy Pill Patients Have Never Taken a GLP-1 Before
Novo's pill has reached 2M scripts and 1M patients in 16 weeks; 80% had never taken a GLP-1 before, and the volume is now changing households, not just balance sheets.
The news. The narrative. The timeline.
Bureau: Chicago
Novo's pill has reached 2M scripts and 1M patients in 16 weeks; 80% had never taken a GLP-1 before, and the volume is now changing households, not just balance sheets.
Both sides of the Alzheimer's drug fight have institutional skin in the game — and the British price-and-coverage decision lands June 10, not in the press cycle.
Friday's IQVIA print is the binary — Foundayo's week-four script count either compresses the 24x gap to Wegovy's pill or breaks RBC's $1.4B FY model.
A 95,490-person Swedish cohort says semaglutide cuts depression risk 44 percent while a ScienceDirect comparator-class study says the opposite — and both designs now sit on the FDA's desk.
VinePair's Ground Signal map prints 262,262 margaritas across 66,583 venues — the retail curve behind it shows tequila up 20 percent quarter-on-quarter in Chicago and 4.8 percent YTD in New Hampshire.
Utah's outbreak passes 638 cases, national 1,814 across 24 outbreaks, 92 percent unvaccinated or unknown — the state DOH and CIDRAP counts diverge by nearly 200.
Day 2 of APHIS's effective-immediately exemption for unaffected-state dairy cattle — Idaho holds 86 confirmed dairy herds and 59 in quarantine across four counties.
Eugene Braunwald, called the father of modern cardiology, died April 22 at 96; the TIMI Study Group and Braunwald's Heart Disease textbook outlive him.